668
Participants
Start Date
May 6, 2014
Primary Completion Date
August 12, 2015
Study Completion Date
March 1, 2019
FTC/TDF
200/300 mg FDC tablets administered orally once daily
F/TAF
Tablets administered orally once daily
Allowed third antiretroviral agent
An allowed third antiretroviral agent of the participant's pre-existing regimen may include one of the following: ritonavir-boosted atazanavir (ATV/r), ritonavir-boosted lopinavir (LPV/r), ritonavir-boosted darunavir (DRV/r), efavirenz (EFV; Sustiva®), rilpivirine (RPV; Edurant®), nevirapine (NVP;Viramune®), raltegravir (RAL; Isentress®), dolutegravir (DTG;Tivicay®), and maraviroc (MVC; Selzentry®).
FTC/TDF Placebo
Tablets administered orally once daily
F/TAF Placebo
Tablets administered orally once daily
CHU Saint-Pierre of Brussels, Brussels
Ricky K. Hsu, MD, PC, New York
Jacobi Medical Center, The Bronx
Montefiore Medical Center, The Bronx
North Shore University Hospital, Manhasset
New York Hospital Queens, Flushing
Dupont Circle Physician's Group, Washington D.C.
Whitman-Walker Health, Washington D.C.
Capital Medical Associates, Washington D.C.
Medical Faculty Associates, Washington D.C.
IRCCS Ospedale San Raffaele, Centro San Luigi, Milan
Azienda Ospedaliera Papa Giovanni XXIII, Bergamo
Infectious Disease Consultants, PA, Charlotte
Atlanta ID Group, Atlanta
AIDS Research Consortium of Atlanta, Atlanta
Mercer University School of Medicine, Macon
Orlando Immunology Center, Orlando
AIDS Research & Treatment Center of the Treasure Coast, Vero Beach
Tarrant County Infectious Disease Associates, Miami
AIDS Healthcare Foundation, Miami Beach
TheraFirst Medical Center, Fort Lauderdale
Gary J. Richmond,M.D.,P.A., Fort Lauderdale
Triple O Research Institute PA, West Palm Beach
AIDS Healthcare Foundation, Tampa
University Hospital of Montpellier (CHU-Gui de Chauliac), Montpellier
Midway Immunology and Research Center, Ft. Pierce
University of Alabama at Birmingham, Birmingham
Ohio State University Medical Center, Columbus
CHU de Nantes Hopital de l'Hotel Dieu, Nantes
Be Well Medical Center, Berkley
Medical College of Wisconsin, Milwaukee
Hennepin County Medical Center, Minneapolis
Centre Hospitalier de Tourcoing, Tourcoing
St. Louis University, St Louis
Southampton Healthcare, Inc., St Louis
The Kc Care Clinic Site 5580, Kansas City
Hopital Bichat Claude Bernard, Paris
Hôpital Tenon, Paris
AIDS Arms, Inc, Dallas
Southwest Infectious Disease Clinical Research, Inc, Dallas
North Texas Infectious Diseases Consulants, Dallas
AIDS Arms, Inc./Trinity Health & Wellness Center, Fort Worth
Therapeutic Concepts, PA, Houston
Gordon E. Crofoot MD PA, Houston
Central Texas Clinical Research, Austin
Kaiser Permanente Colorado, Denver
National Jewish Health, Denver
Apex Research LLC, Denver
Spectrum Medical Group, Phoenix
Southwest CARE Center, Santa Fe
Tarrant County ID Associates, Los Angeles
Southern California Men's Medical Group, Los Angeles
Pacific Oaks Medical Group, Beverly Hills
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance
La Playa Medical Group and Clinical Research, San Diego
Kaiser Permanente Medical Group San Francisco, San Francisco
Kaiser Permanente, Hayward
Highland Hospital - Alameda Health System (formerly Alameda County medical Center), Oakland
Kaiser Permanente Sacramento Medical Center, Sacramento
Peter Shalit, MD, Seattle
Premier Clinical Research, Spokane
Community Research Initiative of New England, Boston
Brigham and Women's Hospital, Boston
Prime Healthcare Services - St Michael's LLC d/b/a Saint Michael's Medical Center, Newark
South Jersey Infectious Disease, Somers Point
Vancouver Infectious Disease Research and Care Centre, Vancouver
Ottawa Hospital-General Campus, Ottawa
Maple Leaf Medical Clinic/Maple Leaf Research, Toronto
University Health Network/Toronto General Hospital, Toronto
Hope Clinical Research, San Juan
Clinical Research Puerto Rico Inc, San Juan
University of Puerto Rico School of Medicine, San Juan
Brighton and Sussex University Hospitals, Brighton
Barts Health NHS Trust, London
Royal Free London NHS Foundation Trust, London
King's College Hospital, London
Chelsea and Westminster Hospital, London
Manchester Centre for Sexual Health, Manchester
Lead Sponsor
Gilead Sciences
INDUSTRY